IR Ingersoll Rand PLC

Delivered Record Third Quarter Orders and Revenue with Strong Gross Margin Expansion, Adj. EPS growth, and Free Cash Flow Margin

Third Quarter 2024 Highlights

(All comparisons against the third quarter of 2023 unless otherwise noted.)

Strong performance driven by its competitive differentiator - Ingersoll Rand Execution Excellence (IRX):

• Third quarter orders of $1,799 million, up 10%
• Reported third quarter revenues of $1,861 million, up 7%
• Reported net income attributable to Ingersoll Rand Inc. of $222 million, or earnings of $0.54 per share
  • Adjusted net income1 of $345 million, or $0.84 per share
• Adjusted EBITDA1 of $533 million, up 15%, with a margin of 28.6%, up 210 basis points year over year
  • Gross margin improvement of 130 basis points
• Reported operating cash flow of $404 million and free cash flow1 of $374 million, up 2%
  • Free cash flow margin1 of 20%
• Liquidity of $4.0 billion as of September 30, 2024, including $1.4 billion of cash on hand and undrawn capacity of $2.6 billion under available credit facilities

2024 Guidance

• Total revenue growth guidance range of 5% to 7% for the full year
• Adjusted EBITDA1 guidance range of $2,010 to $2,040 million, up 12% to 14% over prior year
• Full-year 2024 Adjusted EPS1 guidance range of $3.28 to $3.34, up 11% to 13% over prior year

 

Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, reported strong third quarter 2024 revenues, Adjusted EBITDA, and Adjusted EPS.

“Our Economic Growth Engine remains on track to deliver our long-term Investor Day targets of double-digit Adjusted EPS growth and strong free cash flow generation,” said Vicente Reynal, chairman and chief executive officer of Ingersoll Rand. “We plan on continuing to deploy capital to M&A and drive innovation all while showcasing our ability to deliver sustainable and long-term value as a premier growth compounder.”

Third Quarter 2024 Segment Review

(All comparisons against the third quarter of 2023 unless otherwise noted.)

Industrial Technologies and Services Segment (IT&S): Broad range of compressor, vacuum, blower, and air treatment solutions as well as industrial technologies including power tools and lifting equipment

• Reported Orders of $1,421 million, up 5%, or flat organic
• Reported Revenues of $1,467 million, up 3%, or down 2% organic1
• Reported Segment Adjusted EBITDA of $450 million, up 9%
• Reported Segment Adjusted EBITDA Margin of 30.7%, up 190 basis points, due to IRX enabling strong operational execution driving gross margin expansion.
• IT&S saw positive organic order growth, finishing largely in line with expectations. Book to bill remains on track and consistent with the previous guidance.

__________________________________________

1 Non-GAAP measure (definitions and/or reconciliations in tables below)

Precision and Science Technologies Segment (P&ST): Mission-critical precision liquid, gas, air, and powder handling technologies for life sciences and industrial applications as well as aerospace and defense applications.

• Reported Orders of $378 million, up 30%, or up 3% organic
• Reported Revenues of $394 million, up 27%, or down 3% organic1
• Reported Segment Adjusted EBITDA of $118 million, up 25%
• Reported Segment Adjusted EBITDA Margin of 30.0%, down 30 basis points, driven largely by the Life Sciences businesses
• Organic order growth of low single-digits was driven through demand generation activities and the use of IRX. The performance of the Industrial businesses remains strong with mid-single digit organic orders growth year over year.

Balance Sheet and Cash Flow

Ingersoll Rand remains in a strong financial position with ample liquidity of $4.0 billion. On a reported basis, the Company generated $404 million of cash flow from operating activities and invested $30 million in capital expenditures, resulting in free cash flow1 of $374 million, compared to cash flow from operating activities of $397 million and free cash flow1 of $369 million in the prior year period. Net debt to Adjusted EBITDA leverage2 was 1.7x for the third quarter, which was an increase of 0.8x as compared to the prior year driven primarily by the acquisition of ILC Dover, which took place in the second quarter of 2024.

Consistent with our comprehensive capital allocation strategy led by M&A, in the third quarter of 2024 Ingersoll Rand deployed $15 million to M&A. Ingersoll Rand also closed on multiple acquisitions during the month of October, including:

• Air Power Systems Co., LLC, a leader in the design and manufacturing of fluid power systems for mobile transport equipment expanding Ingersoll Rand’s leading position in the dry and liquid blower and vacuum markets.
• Blutek s.r.l., is a leader in the design and manufacturing of oil-free and lubricated screw-scroll compressors and complete skids for instrument air and nitrogen generation.
• UT Pumps & Systems Private Limited, a leading Indian manufacturer of screw pumps and triplex plunger pumps primarily focused on high-growth, sustainable end markets.
• Penn Valley Pump, a leading manufacturer of unique positive displacement pumps with its Double Disc Pump™ technology for use in the municipal, industrial, chemical and food industries.

We believe that the execution of the Company’s bolt-on acquisition strategy continues to enhance its durable financial profile by serving high-growth, sustainable end markets.

The Company also returned approximately $71 million to shareholders through $63 million in share repurchases and $8 million through its quarterly dividend payment in the third quarter.

__________________________________________

2 Calculated as Net Debt to LTM Adjusted EBITDA

2024 Guidance

Ingersoll Rand is updating its guidance for full-year 2024 Revenue, Adjusted EBITDA, and Adjusted EPS ranges.

 

Key Metrics

 

Previous Guidance

as of 7/31/24

Revised Guidance

as of 10/31/24

Revenue - Total Ingersoll Rand2

6-8%

5-7%

Ingersoll Rand (Organic)1

0-2%

(2)-0%

Industrial Technologies & Services (Organic)1

0-2%

(2)-0%

Precision & Science Technologies (Organic)1

0-2%

(2)-0%

FX Impact3

(~1%)

~Flat

M&A4

~$440M

~$455M

Corporate Costs

(~$170M)

(~$170M)

Adjusted EBITDA1

$2,010M - $2,060M

(+12% - +15% YoY)

$2,010M - $2,040M

(+12% - +14% YoY)

Adjusted EPS1

$3.27 - $3.37

(+10% - +14% YoY)

$3.28 - $3.34

(+11% - +13% YoY)

Reconciliations of non-GAAP measures related to full-year 2024 guidance have not been provided due to the unreasonable efforts it would take to provide such reconciliations due to the high variability, complexity and uncertainty with respect to forecasting and quantifying certain amounts that are necessary for such reconciliations, including net income (loss) and adjustments that could be made for acquisitions-related expenses, restructuring and other business transformation costs, gains or losses on foreign currency exchange and the timing and magnitude of other amounts in the reconciliation of historic numbers. For the same reasons, we are unable to address the probable significance of the unavailable information, which could have a potentially unpredictable, and potentially significant, impact on our future GAAP financial results.

__________________________________________

1 Non-GAAP measure (definitions and/or reconciliations in tables below) 2 All revenue outlook commentary expressed in percentages and based on growth as compared to 2023 3 Based on September 2024 FX rates; does not include impact of FX on M&A 4 Reflects all completed and closed M&A as of October 31, 2024

Conference Call

Ingersoll Rand will host a live earnings conference call to discuss the third quarter results on Friday, November 1, 2024 at 8:00 a.m. (Eastern Time). To participate in the call, please dial 1-888-330-3073, domestically, or 1-646-960-0683, internationally, and use access Code 8970061. A real-time audio webcast of the presentation can be accessed via the Events and Presentations section of the Ingersoll Rand Investor Relations website (https://investors.irco.com), where related materials will be posted prior to the conference call. A replay of the webcast will be available after conclusion of the conference and can be accessed on the Ingersoll Rand Investor Relations website.

Forward-Looking Statements

This news release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to Ingersoll Rand Inc.’s (the “Company” or “Ingersoll Rand”) expectations regarding the performance of its business, its financial results, its liquidity and capital resources and other non-historical statements. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “forecast,” “outlook,” “target,” “endeavor,” “seek,” “predict,” “intend,” “strategy,” “plan,” “may,” “could,” “should,” “will,” “would,” “will be,” “on track to” “will continue,” “will likely result,” “guidance” or the negative thereof or variations thereon or similar terminology generally intended to identify forward-looking statements. All statements other than historical facts are forward-looking statements.

These forward-looking statements are based on Ingersoll Rand’s current expectations and are subject to risks and uncertainties, which may cause actual results to differ materially from these current expectations. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include, among others, (1) adverse impact on our operations and financial performance due to natural disaster, catastrophe, global pandemics, geopolitical tensions, cyber events, or other events outside of our control; (2) unexpected costs, charges or expenses resulting from completed and proposed business combinations; (3) uncertainty of the expected financial performance of the Company; (4) failure to realize the anticipated benefits of completed and proposed business combinations; (5) the ability of the Company to implement its business strategy; (6) difficulties and delays in achieving revenue and cost synergies; (7) inability of the Company to retain and hire key personnel; (8) evolving legal, regulatory and tax regimes; (9) changes in general economic and/or industry specific conditions; (10) actions by third parties, including government agencies; and (11) other risk factors detailed in Ingersoll Rand’s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”), as such factors may be updated from time to time in its periodic filings with the SEC, which are available on the SEC’s website at http://www.sec.gov. The foregoing list of important factors is not exclusive.

Any forward-looking statements speak only as of the date of this release. Ingersoll Rand undertakes no obligation to update any forward-looking statements, whether as a result of new information or developments, future events or otherwise, except as required by law. Readers are cautioned not to place undue reliance on any of these forward-looking statements.

About Ingersoll Rand Inc.

Ingersoll Rand Inc. (NYSE:IR), driven by an entrepreneurial spirit and ownership mindset, is dedicated to Making Life Better for our employees, customers, shareholders, and planet. Customers lean on us for exceptional performance and durability in mission-critical flow creation and life sciences and industrial solutions. Supported by over 80+ respected brands, our products and services excel in the most complex and harsh conditions. Our employees develop customers for life through their daily commitment to expertise, productivity, and efficiency. For more information, visit www.IRCO.com.

Non-U.S. GAAP Measures of Financial Performance

In addition to consolidated GAAP financial measures, Ingersoll Rand reviews various non-GAAP financial measures, including “Organic Revenue Growth/(Decline),” “Adjusted EBITDA,” “Adjusted EBITDA margin,” “Adjusted Net Income,” “Adjusted Diluted EPS,” “Free Cash Flow” and “Free Cash Flow Margin.”

Ingersoll Rand believes Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, and Adjusted Diluted EPS are helpful supplemental measures to assist management and investors in evaluating the Company’s operating results as they exclude certain items that are unusual in nature or whose fluctuation from period to period do not necessarily correspond to changes in the operations of Ingersoll Rand’s business. Ingersoll Rand believes Organic Revenue Growth/(Decline) is helpful supplemental measure to assist management and investors in evaluating the Company’s operating results as it excludes the impact of foreign currency and acquisitions on revenue growth. Adjusted EBITDA represents net income before interest, taxes, depreciation, amortization and certain non-cash, non-recurring and other adjustment items. Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Revenue. Adjusted Net Income is defined as net income including interest, depreciation and amortization of non-acquisition related intangible assets and excluding other items used to calculate Adjusted EBITDA and further adjusted for the tax effect of these exclusions. Organic Revenue Growth/(Decline) is defined as As Reported Revenue growth less the impacts of Foreign Currency and Acquisitions. Ingersoll Rand believes that the adjustments applied in presenting Adjusted EBITDA and Adjusted Net Income are appropriate to provide additional information to investors about certain material non-cash items and about non-recurring items that the Company does not expect to continue at the same level in the future. Adjusted Diluted EPS is defined as Adjusted Net Income divided by Adjusted Diluted Average Shares Outstanding. Incrementals/Decrementals are defined as the change in Adjusted EBITDA versus the prior year period divided by the change in revenue versus the prior year period.

Ingersoll Rand uses Free Cash Flow and Free Cash Flow Margin to review the liquidity of its operations. Ingersoll Rand measures Free Cash Flow as cash flows from operating activities less capital expenditures. Free Cash Flow Margin is defined as Free Cash Flow divided by Revenue. Ingersoll Rand believes Free Cash Flow and Free Cash Flow Margin are useful supplemental financial measures for management and investors in assessing the Company’s ability to pursue business opportunities and investments and to service its debt. Free Cash Flow is not a measure of our liquidity under GAAP and should not be considered as an alternative to cash flows from operating activities.

Management and Ingersoll Rand’s board of directors regularly use these measures as tools in evaluating the Company’s operating and financial performance and in establishing discretionary annual compensation. Such measures are provided in addition to and should not be considered to be a substitute for, or superior to, the comparable measures under GAAP. In addition, Ingersoll Rand believes that Organic Revenue Growth/(Decline), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS, Incrementals/Decrementals, Free Cash Flow and Free Cash Flow Margin are frequently used by investors and other interested parties in the evaluation of issuers, many of which also present Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow and Free Cash Flow Margin when reporting their results in an effort to facilitate an understanding of their operating and financial results and liquidity.

Organic Revenue Growth/(Decline), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow and Free Cash Flow Margin should not be considered as alternatives to revenue growth, net income, diluted earnings per share or any other performance measure derived in accordance with GAAP, or as alternatives to cash flow from operating activities as a measure of our liquidity. Organic Revenue Growth/(Decline), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow and Free Cash Flow Margin have limitations as analytical tools, and you should not consider such measures either in isolation or as substitutes for analyzing Ingersoll Rand’s results as reported under GAAP.

Reconciliations of Organic Revenue Growth/(Decline), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow and Free Cash Flow Margin to their most comparable U.S. GAAP financial metrics for historical periods are presented in the tables below.

Reconciliations of non-GAAP measures related to full-year 2024 guidance have not been provided due to the unreasonable efforts it would take to provide such reconciliations due to the high variability, complexity and uncertainty with respect to forecasting and quantifying certain amounts that are necessary for such reconciliations, including net income (loss) and adjustments that could be made for acquisitions-related expenses, restructuring and other business transformation costs, gains or losses on foreign currency exchange and the timing and magnitude of other amounts in the reconciliation of historic numbers. For the same reasons, we are unable to address the probable significance of the unavailable information, which could have a potentially unpredictable, and potentially significant, impact on our future GAAP financial results.

INGERSOLL RAND INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited; in millions, except per share amounts)

 

 

For the Three Month Period

Ended September 30,

 

For the Nine Month Period

Ended September 30,

 

2024

 

2023

 

2024

 

2023

Revenues

$

1,861.0

 

 

$

1,738.9

 

 

$

5,336.4

 

 

$

5,054.7

 

Cost of sales

 

1,046.0

 

 

 

999.6

 

 

 

2,981.8

 

 

 

2,953.7

 

Gross Profit

 

815.0

 

 

 

739.3

 

 

 

2,354.6

 

 

 

2,101.0

 

Selling and administrative expenses

 

334.3

 

 

 

315.2

 

 

 

1,012.7

 

 

 

941.9

 

Amortization of intangible assets

 

95.0

 

 

 

92.2

 

 

 

277.8

 

 

 

274.3

 

Other operating expense, net

 

29.4

 

 

 

13.5

 

 

 

142.8

 

 

 

53.7

 

Operating Income

 

356.3

 

 

 

318.4

 

 

 

921.3

 

 

 

831.1

 

Interest expense

 

63.8

 

 

 

39.6

 

 

 

151.4

 

 

 

119.3

 

Loss on extinguishment of debt

 

—

 

 

 

12.6

 

 

 

3.0

 

 

 

13.5

 

Other income, net

 

(9.5

)

 

 

(7.6

)

 

 

(40.8

)

 

 

(25.4

)

Income Before Income Taxes

 

302.0

 

 

 

273.8

 

 

 

807.7

 

 

 

723.7

 

Provision for income taxes

 

73.8

 

 

 

60.3

 

 

 

174.3

 

 

 

168.9

 

Loss on equity method investments

 

(4.8

)

 

 

(3.9

)

 

 

(19.0

)

 

 

(1.2

)

Net Income

 

223.4

 

 

 

209.6

 

 

 

614.4

 

 

 

553.6

 

Less: Net income attributable to noncontrolling interests

 

1.8

 

 

 

1.3

 

 

 

5.6

 

 

 

4.7

 

Net Income Attributable to Ingersoll Rand Inc.

$

221.6

 

 

$

208.3

 

 

$

608.8

 

 

$

548.9

 

 

 

 

 

 

 

 

 

Basic earnings per share

 

0.55

 

 

 

0.51

 

 

 

1.51

 

 

 

1.36

 

Diluted earnings per share

 

0.54

 

 

 

0.51

 

 

 

1.49

 

 

 

1.34

 

INGERSOLL RAND INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Unaudited; in millions, except share amounts)

 

 

September 30,

2024

 

December 31,

2023

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

1,376.9

 

 

$

1,595.5

 

Accounts receivable, net of allowance for credit losses of $57.9 and $53.8, respectively

 

1,342.2

 

 

 

1,234.2

 

Inventories

 

1,162.5

 

 

 

1,001.1

 

Other current assets

 

309.6

 

 

 

219.6

 

Total current assets

 

4,191.2

 

 

 

4,050.4

 

Property, plant and equipment, net of accumulated depreciation of $567.4 and $500.8, respectively

 

853.1

 

 

 

711.4

 

Goodwill

 

8,206.2

 

 

 

6,609.7

 

Other intangible assets, net

 

4,445.8

 

 

 

3,611.1

 

Deferred tax assets

 

30.3

 

 

 

31.5

 

Other assets

 

479.6

 

 

 

549.4

 

Total assets

$

18,206.2

 

 

$

15,563.5

 

Liabilities and Stockholders' Equity

 

 

 

Current liabilities:

 

 

 

Short-term borrowings and current maturities of long-term debt

$

2.9

 

 

$

30.6

 

Accounts payable

 

743.8

 

 

 

801.2

 

Accrued liabilities

 

1,028.9

 

 

 

995.5

 

Total current liabilities

 

1,775.6

 

 

 

1,827.3

 

Long-term debt, less current maturities

 

4,782.5

 

 

 

2,693.0

 

Pensions and other postretirement benefits

 

153.1

 

 

 

150.0

 

Deferred income tax liabilities

 

802.7

 

 

 

612.6

 

Other liabilities

 

358.1

 

 

 

433.9

 

Total liabilities

$

7,872.0

 

 

$

5,716.8

 

Stockholders' equity:

 

 

 

Common stock, $0.01 par value; 1,000,000,000 shares authorized; 430,614,342 and 428,589,061 shares issued as of September 30, 2024 and December 31, 2023, respectively

 

4.3

 

 

 

4.3

 

Capital in excess of par value

 

9,614.9

 

 

 

9,550.8

 

Retained earnings

 

2,281.8

 

 

 

1,697.2

 

Accumulated other comprehensive loss

 

(202.1

)

 

 

(227.6

)

Treasury stock at cost; 27,252,719 and 25,241,667 shares as of September 30, 2024 and December 31, 2023, respectively

 

(1,431.3

)

 

 

(1,240.9

)

Total Ingersoll Rand stockholders' equity

$

10,267.6

 

 

$

9,783.8

 

Noncontrolling interests

 

66.6

 

 

 

62.9

 

Total stockholders' equity

$

10,334.2

 

 

$

9,846.7

 

Total liabilities and stockholders' equity

$

18,206.2

 

 

$

15,563.5

 

INGERSOLL RAND INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited; in millions)

 

 

Nine Month Period

Ended September 30,

 

2024

 

2023

Cash Flows From Operating Activities:

 

 

Net income

$

614.4

 

 

$

553.6

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

Amortization of intangible assets

 

277.8

 

 

 

274.3

 

Depreciation

 

80.6

 

 

 

67.2

 

Non-cash restructuring charges

 

1.6

 

 

 

2.1

 

Stock-based compensation expense

 

43.6

 

 

 

35.2

 

Loss on equity method investments

 

19.0

 

 

 

1.2

 

Foreign currency transaction losses, net

 

9.2

 

 

 

1.0

 

Non-cash adjustments to carrying value of LIFO inventories

 

7.2

 

 

 

14.0

 

Loss on extinguishment of debt

 

3.0

 

 

 

13.5

 

Loss on sale of asbestos-related assets and liabilities

 

33.7

 

 

 

—

 

Other non-cash adjustments

 

5.2

 

 

 

7.4

 

Changes in assets and liabilities:

 

 

 

Receivables

 

(17.9

)

 

 

(62.2

)

Inventories

 

(40.1

)

 

 

10.0

 

Accounts payable

 

(95.6

)

 

 

(140.8

)

Accrued liabilities

 

5.0

 

 

 

82.1

 

Other assets and liabilities, net

 

(76.2

)

 

 

(62.6

)

Net cash provided by operating activities

 

870.5

 

 

 

796.0

 

Cash Flows Used In Investing Activities:

 

 

 

Capital expenditures

 

(113.8

)

 

 

(75.8

)

Net cash paid in acquisitions

 

(2,759.1

)

 

 

(923.8

)

Disposals of property, plant and equipment

 

6.1

 

 

 

7.6

 

Other investing

 

(6.0

)

 

 

0.3

 

Net cash used in investing activities

 

(2,872.8

)

 

 

(991.7

)

Cash Flows From (Used In) Financing Activities:

 

 

 

Principal payments on long-term debt

 

(1,241.8

)

 

 

(1,510.8

)

Proceeds from long-term debt

 

3,296.9

 

 

 

1,490.4

 

Purchases of treasury stock

 

(198.2

)

 

 

(132.9

)

Cash dividends on common shares

 

(24.2

)

 

 

(24.3

)

Proceeds from stock option exercises

 

28.3

 

 

 

21.9

 

Payments to settle cross-currency swaps

 

(19.9

)

 

 

—

 

Payments of deferred and contingent acquisition consideration

 

(22.6

)

 

 

(17.4

)

Payments of debt issuance costs

 

(32.3

)

 

 

(17.3

)

Other financing

 

(3.5

)

 

 

(3.4

)

Net cash provided by (used in) financing activities

 

1,782.7

 

 

 

(193.8

)

Effect of exchange rate changes on cash and cash equivalents

 

1.0

 

 

 

(26.0

)

Net decrease in cash and cash equivalents

 

(218.6

)

 

 

(415.5

)

Cash and cash equivalents, beginning of period

 

1,595.5

 

 

 

1,613.0

 

Cash and cash equivalents, end of period

$

1,376.9

 

 

$

1,197.5

 

INGERSOLL RAND INC. AND SUBSIDIARIES

UNAUDITED ADJUSTED FINANCIAL INFORMATION

(Dollars in millions)

 

 

For the Three Month Period

Ended September 30,

 

For the Nine Month Period

Ended September 30,

 

2024

 

2023

 

2024

 

2023

Revenues

$

1,861.0

 

 

$

1,738.9

 

 

$

5,336.4

 

 

$

5,054.7

 

Adjusted EBITDA

$

532.7

 

 

$

461.5

 

 

$

1,485.8

 

 

$

1,286.3

 

Adjusted EBITDA Margin

 

28.6

%

 

 

26.5

%

 

 

27.8

%

 

 

25.4

%

Free Cash Flow

$

374.3

 

 

$

368.7

 

 

$

756.7

 

 

$

720.2

 

Free Cash Flow Margin

 

20.1

%

 

 

21.2

%

 

 

14.2

%

 

 

14.2

%

INGERSOLL RAND INC. AND SUBSIDIARIES

RECONCILIATION OF NET INCOME TO ADJUSTED NET INCOME AND ADJUSTED NET INCOME ATTRIBUTABLE TO INGERSOLL RAND AND ADJUSTED DILUTED EARNINGS PER SHARE

(Unaudited; in millions)

 

 

For the Three Month Period

Ended September 30,

 

For the Nine Month Period

Ended September 30,

 

2024

 

2023

 

2024

 

2023

Net Income

$

223.4

 

$

209.6

 

 

$

614.4

 

$

553.6

 

Plus:

 

 

 

 

 

 

 

Provision for income taxes

 

73.8

 

 

60.3

 

 

 

174.3

 

 

168.9

 

Amortization of acquisition related intangible assets

 

92.7

 

 

89.8

 

 

 

271.3

 

 

266.7

 

Restructuring and related business transformation costs

 

9.7

 

 

2.2

 

 

 

24.3

 

 

12.4

 

Acquisition and other transaction related expenses and non-cash charges

 

16.5

 

 

14.8

 

 

 

59.5

 

 

46.6

 

Stock-based compensation

 

15.0

 

 

11.2

 

 

 

43.6

 

 

35.2

 

Foreign currency transaction losses, net

 

9.9

 

 

1.1

 

 

 

9.2

 

 

1.0

 

Loss on equity method investments

 

4.8

 

 

3.9

 

 

 

19.0

 

 

1.2

 

Loss on extinguishment of debt

 

—

 

 

12.6

 

 

 

3.0

 

 

13.5

 

Adjustments to LIFO inventories

 

—

 

 

(0.3

)

 

 

7.2

 

 

14.0

 

Cybersecurity incident costs

 

—

 

 

0.1

 

 

 

0.5

 

 

2.3

 

Loss on asbestos sale

 

—

 

 

—

 

 

 

58.8

 

 

—

 

Other adjustments

 

0.6

 

 

(0.3

)

 

 

1.0

 

 

(1.7

)

Minus:

 

 

 

 

 

 

 

Income tax provision, as adjusted

 

101.7

 

 

89.0

 

 

 

280.4

 

 

252.5

 

Adjusted Net Income

 

344.7

 

 

316.0

 

 

 

1,005.7

 

 

861.2

 

Less: Net income attributable to noncontrolling interest

 

1.8

 

 

1.3

 

 

 

5.6

 

 

4.7

 

Adjusted Net Income Attributable to Ingersoll Rand Inc.

$

342.9

 

$

314.7

 

 

$

1,000.1

 

$

856.5

 

 

 

 

 

 

 

 

 

Adjusted Basic Earnings Per Share1

$

0.85

 

$

0.78

 

 

$

2.48

 

$

2.12

 

Adjusted Diluted Earnings Per Share2

$

0.84

 

$

0.77

 

 

$

2.45

 

$

2.09

 

 

 

 

 

 

 

 

 

Average shares outstanding:

 

 

 

 

 

 

 

Basic, as reported

 

403.4

 

 

404.5

 

 

 

403.5

 

 

404.8

 

Diluted, as reported

 

406.9

 

 

408.6

 

 

 

407.4

 

 

408.9

 

Adjusted diluted2

 

406.9

 

 

408.6

 

 

 

407.4

 

 

408.9

 

1 Basic and diluted earnings per share (as reported) are calculated by dividing net income attributable to Ingersoll Rand Inc. by the basic and diluted average shares outstanding for the respective periods.

2 Adjusted diluted share count and adjusted diluted earnings per share include incremental dilutive shares, using the treasury stock method, which are added to average shares outstanding.

INGERSOLL RAND INC. AND SUBSIDIARIES

RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA AND ADJUSTED NET INCOME AND CASH FLOWS FROM OPERATING ACTIVITIES TO FREE CASH FLOW

(Unaudited; in millions)

 

 

For the Three Month Period

Ended September 30,

 

For the Nine Month Period

Ended September 30,

 

2024

 

2023

 

2024

 

2023

Net Income

$

223.4

 

 

$

209.6

 

 

$

614.4

 

 

$

553.6

 

Plus:

 

 

 

 

 

 

 

Interest expense

 

63.8

 

 

 

39.6

 

 

 

151.4

 

 

 

119.3

 

Provision for income taxes

 

73.8

 

 

 

60.3

 

 

 

174.3

 

 

 

168.9

 

Depreciation expense

 

28.2

 

 

 

22.4

 

 

 

77.5

 

 

 

64.4

 

Amortization expense

 

95.0

 

 

 

92.2

 

 

 

277.8

 

 

 

274.3

 

Restructuring and related business transformation costs

 

9.7

 

 

 

2.2

 

 

 

24.3

 

 

 

12.4

 

Acquisition and other transaction related expenses and non-cash charges

 

16.5

 

 

 

14.8

 

 

 

59.5

 

 

 

46.6

 

Stock-based compensation

 

15.0

 

 

 

11.2

 

 

 

43.6

 

 

 

35.2

 

Foreign currency transaction losses, net

 

9.9

 

 

 

1.1

 

 

 

9.2

 

 

 

1.0

 

Loss on equity method investments

 

4.8

 

 

 

3.9

 

 

 

19.0

 

 

 

1.2

 

Loss on extinguishment of debt

 

—

 

 

 

12.6

 

 

 

3.0

 

 

 

13.5

 

Adjustments to LIFO inventories

 

—

 

 

 

(0.3

)

 

 

7.2

 

 

 

14.0

 

Cybersecurity incident costs

 

—

 

 

 

0.1

 

 

 

0.5

 

 

 

2.3

 

Loss on asbestos sale

 

—

 

 

 

—

 

 

 

58.8

 

 

 

—

 

Interest income on cash and cash equivalents

 

(8.0

)

 

 

(7.9

)

 

 

(35.7

)

 

 

(18.7

)

Other adjustments

 

0.6

 

 

 

(0.3

)

 

 

1.0

 

 

 

(1.7

)

Adjusted EBITDA

$

532.7

 

 

$

461.5

 

 

$

1,485.8

 

 

$

1,286.3

 

Minus:

 

 

 

 

 

 

 

Interest expense

 

63.8

 

 

 

39.6

 

 

 

151.4

 

 

 

119.3

 

Income tax provision, as adjusted

 

101.7

 

 

 

89.0

 

 

 

280.4

 

 

 

252.5

 

Depreciation expense

 

28.2

 

 

 

22.4

 

 

 

77.5

 

 

 

64.4

 

Amortization of non-acquisition related intangible assets

 

2.3

 

 

 

2.4

 

 

 

6.5

 

 

 

7.6

 

Interest income on cash and cash equivalents

 

(8.0

)

 

 

(7.9

)

 

 

(35.7

)

 

 

(18.7

)

Adjusted Net Income

$

344.7

 

 

$

316.0

 

 

$

1,005.7

 

 

$

861.2

 

 

 

 

 

 

 

 

 

Free Cash Flow:

 

 

 

 

 

 

 

Cash flows from operating activities

$

404.0

 

 

$

397.3

 

 

$

870.5

 

 

$

796.0

 

Minus:

 

 

 

 

 

 

 

Capital expenditures

 

29.7

 

 

 

28.6

 

 

 

113.8

 

 

 

75.8

 

Free Cash Flow

$

374.3

 

 

$

368.7

 

 

$

756.7

 

 

$

720.2

 

INGERSOLL RAND INC. AND SUBSIDIARIES

RECONCILIATION OF SEGMENT ADJUSTED EBITDA TO NET INCOME

(Unaudited; in millions)

 

 

For the Three Month Period

Ended September 30,

 

For the Nine Month Period

Ended September 30,

 

2024

 

2023

 

2024

 

2023

Orders

 

 

 

 

 

 

 

Industrial Technologies and Services

$

1,420.6

 

 

$

1,346.9

 

 

$

4,284.4

 

 

$

4,241.5

 

Precision and Science Technologies

 

378.1

 

 

 

290.9

 

 

 

1,021.1

 

 

 

910.5

 

Total Orders

$

1,798.7

 

 

$

1,637.8

 

 

$

5,305.5

 

 

$

5,152.0

 

Revenue

 

 

 

 

 

 

 

Industrial Technologies and Services

$

1,467.2

 

 

$

1,428.4

 

 

$

4,307.1

 

 

$

4,124.0

 

Precision and Science Technologies

 

393.8

 

 

 

310.5

 

 

 

1,029.3

 

 

 

930.7

 

Total Revenue

$

1,861.0

 

 

$

1,738.9

 

 

$

5,336.4

 

 

$

5,054.7

 

Segment Adjusted EBITDA

 

 

 

 

 

 

 

Industrial Technologies and Services

$

449.9

 

 

$

410.9

 

 

$

1,297.2

 

 

$

1,134.0

 

Precision and Science Technologies

 

118.1

 

 

 

94.2

 

 

 

312.0

 

 

 

278.7

 

Total Segment Adjusted EBITDA

$

568.0

 

 

$

505.1

 

 

$

1,609.2

 

 

$

1,412.7

 

Less items to reconcile Segment Adjusted EBITDA to Income Before Income Taxes:

 

 

 

 

 

 

 

Corporate expenses not allocated to segments

$

35.3

 

 

$

43.6

 

 

$

123.4

 

 

$

126.4

 

Interest expense

 

63.8

 

 

 

39.6

 

 

 

151.4

 

 

 

119.3

 

Depreciation and amortization expense

 

123.2

 

 

 

114.6

 

 

 

355.3

 

 

 

338.7

 

Restructuring and related business transformation costs

 

9.7

 

 

 

2.2

 

 

 

24.3

 

 

 

12.4

 

Acquisition and other transaction related expenses and non-cash charges

 

16.5

 

 

 

14.8

 

 

 

59.5

 

 

 

46.6

 

Stock-based compensation

 

15.0

 

 

 

11.2

 

 

 

43.6

 

 

 

35.2

 

Foreign currency transaction losses, net

 

9.9

 

 

 

1.1

 

 

 

9.2

 

 

 

1.0

 

Loss on extinguishment of debt

 

—

 

 

 

12.6

 

 

 

3.0

 

 

 

13.5

 

Adjustments to LIFO inventories

 

—

 

 

 

(0.3

)

 

 

7.2

 

 

 

14.0

 

Cybersecurity incident costs

 

—

 

 

 

0.1

 

 

 

0.5

 

 

 

2.3

 

Loss on asbestos sale

 

—

 

 

 

—

 

 

 

58.8

 

 

 

—

 

Interest income on cash and cash equivalents

 

(8.0

)

 

 

(7.9

)

 

 

(35.7

)

 

 

(18.7

)

Other adjustments

 

0.6

 

 

 

(0.3

)

 

 

1.0

 

 

 

(1.7

)

Income Before Income Taxes

 

302.0

 

 

 

273.8

 

 

 

807.7

 

 

 

723.7

 

Provision for income taxes

 

73.8

 

 

 

60.3

 

 

 

174.3

 

 

 

168.9

 

Loss on equity method investments

 

(4.8

)

 

 

(3.9

)

 

 

(19.0

)

 

 

(1.2

)

Net Income

$

223.4

 

 

$

209.6

 

 

$

614.4

 

 

$

553.6

 

INGERSOLL RAND INC. AND SUBSIDIARIES

ORDERS AND REVENUE GROWTH (DECLINE) BY SEGMENT1

 

 

For the Three Month Period

Ended September 30, 2024

 

Orders

 

Revenue

Ingersoll Rand

 

 

 

Organic growth (decline)

0.8

%

 

(2.4

%)

Impact of foreign currency

0.3

%

 

0.5

%

Impact of acquisitions

8.7

%

 

8.9

%

Total orders and revenue growth

9.8

%

 

7.0

%

 

 

 

 

Industrial Technologies & Services

 

 

 

Organic growth (decline)

0.4

%

 

(2.2

%)

Impact of foreign currency

0.3

%

 

0.4

%

Impact of acquisitions

4.8

%

 

4.5

%

Total orders and revenue growth

5.5

%

 

2.7

%

 

 

 

 

Precision & Science Technologies

 

 

 

Organic growth (decline)

2.6

%

 

(3.2

%)

Impact of foreign currency

1.0

%

 

0.9

%

Impact of acquisitions

26.4

%

 

29.1

%

Total orders and revenue growth

30.0

%

 

26.8

%

1 Organic growth/(decline), impact of foreign currency, and impact of acquisitions are non-GAAP measures. References to “impact of acquisitions” refer to GAAP sales from acquired businesses recorded prior to the first anniversary of the acquisition. The portion of GAAP revenue attributable to currency translation is calculated as the difference between (a) the period-to-period change in revenue (excluding acquisition sales) and (b) the period-to-period change in revenue (excluding acquisition sales) after applying prior year foreign exchange rates to the current year period.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20241031346025/en/

Investor Relations: Matthew Fort Matthew.Fort@irco.com

Media: Sara Hassell Sara.Hassell@irco.com